Legal Representation
Attorney
Haverly MacArthur
USPTO Deadlines
Next Deadline
14 days remaining
Notice of Publication
Due Date
August 14, 2025
Extension Available
Until September 14, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 15, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 15, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 9, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 10, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 2, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 2, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 2, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 20, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Mar 6, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 6, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 6, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 6, 2025 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Mar 22, 2024 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Mar 15, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 8, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 8, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 8, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 8, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 6, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 20, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 20, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and medical and veterinary preparations for strengthening the immune system and restoring normal bodily functions; pharmaceutical preparations and medical and veterinary preparations for the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders and obesity; pharmaceutical preparations and medical and veterinary preparations for central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, and ocular motility; pharmaceutical preparations and medical and veterinary preparations for respiratory diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for excretory diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for cardiovascular diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for reproductive diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for endocrinal diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, and hepatitis; pharmaceutical preparations and medical and veterinary preparations for dermatological diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for bone diseases, back pain, muscular dystrophy and inflammatory muscle diseases; pharmaceutical preparations and medical and veterinary preparations for blindness; sanitary preparations for medical purposes and for personal hygiene, other than toiletries; dietetic food and substances adapted for medical or and veterinary use; food for babies; dietary supplements for human beings and animals; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; nutritional supplements; Chinese patent medicines, namely, herbal medicines for the treatment of tumors and for enhancing the immune system; herbal supplements, namely, lingzhi; herbal supplements, namely, yunzhi; herbal supplements in the form of granules, pills, capsules and tablets containing yunzhi for the treatment of cancer and cancer affections; herbal supplements in the form of granules, pills, capsules and tablets containing lingzhi for the treatment of cancer and cancer affections; herbal supplements containing yunzhi (corioulus versicolor) in the form of capsules, granules, pills and tablets for the treatment of tumors and for enhancing the immune system
Classification
International Classes
005